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Morbidityandmortalityafterpneumonectomyinsmokers
with NSCLC
Komplikationen und Mortalität nach Pneumonektomie bei Rauchern
mit NSCLC
Abstract
Objective: Perioperative morbidity and mortality in patients receiving
pneumonectomybecauseofnon-smallcelllungcancer(NSCLC)remains
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1 Patients and method: The results of 156 Patients who received pneu-
monectomy between 1995 and 2004 were reviewed retrospectively.
All patients had stage I or II NSCLC. In 81 cases a right sided and in 75
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tests were sufficient for pneumonectomy. Pneumology and Thoracic
Results: Overall perioperative 30-day mortality was 7.1% (n=11), in
hospitalmortality8.3%(n=13).Thecausewassepsisin6cases,cardiac
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failurein4cases,andrespiratoryinsufficiencyin3cases.Inunivariable Hospital, Gerlingen,
Deutschland andmultivariableregressionanalysisconsideringmortality,noneofthe
prognosticfactorsreachedsignificance.Theoddsratioforpostoperative 2 DepartmentofMathematics,
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deathwas1.6foldforsmokersincomparisontononsmokers.Complic-
ations after pneumonectomy were seen in 34.6%, with arrhythmia in
16.0%, sepsis in 1.9% and bronchopleural fistula (BPF) occurring in
6.4%. Smoking and intraoperative blood loss >500 ml were highly sig-
nificant perioperative risk factors.
Conclusion:Smokinguntiloperationandintraoperativebloodlosswere
independent postoperative risk factors leading to complications after
pneumonectomy for NSCLC. The risk for complications was 2.8-fold
higher for smokers.
Keywords: pneumonectomy, risk factor, morbidity, mortality,
complications, smoking
Zusammenfassung
Ziel: Nach wie vor ist die perioperative Morbidität und Mortalität bei
Patienten,diesichaufGrundeinesnicht-kleinzelligemLungenkarzinoms
einerPneumonektomieunterziehenmüssen,sehrhoch.DasZieldieser
Studie ist, Risikofaktoren zu identifizieren und dadurch die Morbidität
und Mortalität zu senken.
Patienten und Methode: Die Daten von 156 Patienten, die zwischen
1995 und 2004 auf Grund eines nicht-kleinzelligen Lungenkarzinoms
im Stadium I und II pneumonektomiert werden mussten, wurden retro-
spektiv ausgewertet. In 81 Fällen wurde die Pneumonektomie rechts
und in 75 Fällen links vorgenommen. Sowohl kardiale als auch pulmo-
nale Funktionsparameter qualifizierten die Patienten für eine Pneumo-
nektomie.
Resultate:Die30-Tage-Mortalitätbetrug7,1%(n=11),dieKrankenhaus-
letalität 8,3% (n=13). Die Ursachen waren eine Sepsis bei 6 Patienten,
Herzversagenbei4PatientenundpulmonaleProblemebei3Patienten.
Bezüglich der Letalität erreichte keiner der Prognosefaktoren sowohl
in der univariablen als auch der multivariablen Regression statistische
Signifikanz. Die Odds-Ratio, postoperativ zu versterben, betrug bei den
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Research Article OPEN ACCESSRauchern 1,6. Komplikationen traten in 34,6% auf, am häufigsten Ar-
rhythmie bei 16,0%, Sepsis in 1,9% und Bronchusstumpfinsuffizienz in
6,4%. Rauchen und intraoperativer Blutverlust >500 ml waren hoch
signifikante perioperative Risikofaktoren.
Schlussfolgerung: Rauchen bis zur Operation und intraoperativer Blut-
verlust sind unabhängige perioperative Risikofaktoren nach Pneumo-
nektomiebeinicht-kleinzelligemLungenkarzinom.DasRisiko,postope-
rativ Komplikationen zu entwickeln, war 2,8-mal höher bei Rauchern.
Schlüsselwörter:Pneumonektomie,Risikofaktor,Morbidität,Mortalität,
Komplikationen, Rauchen
Introduction
Lung cancer remains the leading cause of cancer death
throughouttheworldwith1.2millionnewcasesannually.
Complete resection continues to be the only way to
eliminate lung cancer. Because of improved surgical
technique and perioperative care, the outcome after
pulmonary resection has greatly improved throughout
recentyears[1].However,pneumonectomyresultsinthe
highest morbidity and mortality of thoracic procedures
with pneumonectomy necessary for complete resection
of non-small cell lung cancer (NSCLC) in about 10–30%
of resectable cases [2], [3]. The perioperative 30-day
mortalityhasbeenreportedashighas25–40%inrecent
scientific literature [4], [5], [6]. The most common cause
forperioperativemortalityispostoperativebronchopleural
fistula(BPF).Theuseofmonofilamentabsorbablesutures
for closure of the bronchial stump decreases the rate of
BPFsignificantly[7].Buttressingthebronchialstumpwith
viablemateriallikepericardiumordifferentmusclescould
give additional security [8]. Several studies dealing with
pre- and perioperative risk factors of patients requiring
pneumonectomyreachdifferentconclusions[3],[9],[10],
[11], [12], [13]. The different conclusions are due to a
low number of patients and inappropriate statistic meth-
ods in most studies which leads to contradictory results
with some minor impact for clinical work. Mortality rates
could be decreased 6–15% with proper selection of pro-
cedures [14], [15]. Therefore, we have reviewed the role
of smoking and other risk factors in patients requiring
pneumonectomy because of NSCLC over the past
10 years. To exclude factors related to advanced cancer,
only patients with early stage lung cancer were included.
Cigarette smoking is a significant and preventable cause
of morbidity and mortality and has also been implicated
asariskfactorforpostoperativepulmonarycomplications
[5]. Previous studies have found that current smokers
aretwotofourtimesmorelikelytodeveloppostoperative
complications [16].
Patients and methods
AllpatientsundergoingpneumonectomyforstageIandII
lung cancer at Schillerhöhe Hospital between
January 1995 and June 2004 were retrospectively iden-
tified and reviewed. Patients with stage-III NSCLC have
received neoadjuvant chemoradiotherapy since 1995 in
our hospital. Despite additional factors related to ad-
vancedcancertreatment,relatedmorbidityandmortality
played a major role in these patients and we decided not
to consider them in this study.
All data were analyzed for pre- or intraoperative factors
related to an increase in postoperative morbidity and
mortality. Mortality was defined as death within 30 days
after pneumonectomy. All postoperative complications
whichrequiredtreatmentweredocumented.Thefollowing
demographic data were collected for all patients: Age,
sex, weight, stage, number of additional diseases,
smoking, ASA score, side of operation, operation time,
andintraoperativebloodloss.Accordingtotheguidelines
of the German Society for Thoracic Surgery, all patients
hadsufficientcardio-pulmonaryreservesforpneumonec-
tomy. The preoperative evaluation included a complete
history, physical examination, blood cell count, biochem-
icalprofile,chestX-ray,ECGandpulmonaryfunctiontests.
Preoperative staging required bronchoscopy, CT thorax,
CTbrain,bonescan,andultrasoundofabdomen.Resec-
tion was standardized in all patients with posterolateral
thoracotomy following dissection of the hilar structures
confirming resectability. After resection, free margins at
the bronchial stump were documented by frozen section
and the bronchial stump was closed by interrupted 3.0
and 4.0 PDS sutures in all patients. Buttressing was not
done routinely. Complete lymphadenectomy of
sections2–4,7–9,and10inrightsidedand4–10inleft
sided tumors was done routinely. All patients were mon-
itored at ICU for a minimum of 5 days.
Statistics were accomplished using the software R
(http://www.r-project.org/). For comparison of signific-
ances, a Fisher exact test was used for categorical vari-
ables. Univariable and multivariable regression analysis
was used for exploring significant prognostic factors be-
fore the odds ratio was calculated.
Results
Between 1995 and 2004, 156 patients (125 male,
31 female) with stage I or II NSCLC underwent pneumon-
ectomy. Median age was 63 years; Karnofsky Index was
100in79%;and84%hadnomajorcomorbiditywithonly
one having an additional disease. ASA score was 3 in
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side and 48% (n=75) left side tumors (Table 1).
Table 1: Demographic data (n=156)
59% (n=92) of the patients smoked until operation. Dur-
ing this time, no program for smoking cessation was
offered at our hospital. 57 patients had more than
30 pack years. Smoker data are shown in Table 2.
Table 2: Smokers and nonsmokers in comparison
Mortality
30-daymortalitywas7.1%(n=11)(9male,2female)and
hospitalmortalitywas8.3%(n=13).Thecausewassepsis
in 3.2% (n=6) because of advanced pneumonia or bron-
chopleural fistula, cardiac failure in 2.6% (n=4) and pul-
monary failure in 1.2% (n=1).
Table 3 presents the results of univariable regression
analysis. In the group of smokers, hospital mortality was
9.8% (n=9) while mortality in non smokers was 6.2%
(n=4) which was not significant in χ
2 test (p< 0.56). The
Odds ratio (OR) to die within 30 days after pneumonec-
tomywas1.6forsmokers.Otherprognosticfactors–ASA
score, age, intraoperative blood loss and operation time
– did not reach significance.
Table 3: Univariable regression analysis: mortality
OR = Odds ratio, ASA = ASA score
Morbidity
Postoperative complications occurred in 34.6% (n=54)
patients. As shown in Table 4, the most common prob-
lemswhichrequiredtreatmentwerearrhythmiain16.0%
(n=25), BPF in 6.4% (n=10), sepsis in 5.7% (n=9),
haemorrhage which required reoperation in 3.8% (n=6),
and recurrent nerve palsy in 2.5% (n=4).
Table 4: Incidence of postoperative complications
Age over 60 years, and operation time >4 hours were
significant risk factors for developing postoperative
complications.Intraoperativebloodlossover500mland
smoking were highly significant prognostic factors for
postoperative complications (Table 5). Postoperative
complicationsoccurredin39(42.4%)smokersandin15
(23.4%) nonsmokers, this was significant in χ
2-test
(p=0.01). This means that smokers have an OR of 2.4
for developing postoperative complications. When intra-
operative blood loss was more than 500 ml the OR for
developing postoperative complications was 2.6.
Arrhythmia, sepsis and postoperative haemorrhage ap-
peared significant more often in smokers than in
nonsmokers (Table 6). BPF appeared in 8 smokers and
in only 2 nonsmokers with an OR of 1.3.
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OR = Odds ratio, ASA = ASA score
Table 6: Multivariable regression analysis: complications considering smoking
OR = Odds ratio
Discussion
Pneumonectomy continues to be an important routine
resection procedure in lung cancer surgery. In a study
involving 1905 operated patients with lung cancer, the
percentage of patients undergoing pneumonectomy was
16.5% [17]. Improvements in surgical technique, anaes-
thesia, and perioperative care resulted in a decrease in
morbidity and mortality rates in major pulmonary resec-
tions. Despite these improvements, pneumonectomy
persistently has the highest rates of morbidity and mor-
tality of pulmonary resections.
The present study examined the postoperative course of
patients undergoing pneumonectomy for stage I and II
NSCLC and evaluated the importance of perioperative
risk factors as predictors for postoperative death and
complications.Wefoundthatpostoperativecomplications
occurred in 35% and mortality was 8.3%. Considering
perioperativedeath,noneoftheperioperativeriskfactors
reached significance within our cohort of 156 patients.
Surprisingly, the OR was only a moderate increase in
smokers and, against our expectations, smoking until
surgery had no major impact on 30-day mortality after
pneumonectomyinNSCLC.Perioperativemortalityfollow-
ing pneumonectomy ranges from 3 to 33% in different
publications[18].[19].Inastudyonthequalityofsurgery
in lung cancer carried out in various German clinics, the
mortality rate following pneumonectomy varied from 4 to
33% [14]. Ginsberg found an increase in mortality rate
inpatientsolderthan70years[20].Incontrast,Cuifound
no correlation between mortality in 1738 patients with
age >60 years [18].
Smoking, age, intraoperative blood loss and operation
time had a significant impact on morbidity in the univari-
ate regression analysis (p<0.05). Patients who smoked
up to the time of operation had 2.8-fold higher morbidity
and a 1.6-fold higher mortality. However, we could not
selectanyofthepreoperativeriskfactorsresponsiblefor
mortality after pneumonectomy in smokers.
Onlyafewreportshavedealtwithsmokingasaperioper-
ative risk factor. Algar et al. determined the effect of
smoking on perioperative mortality in 267 patients but
was unable to show a significant relationship (p =0.28)
[21]. Licker et al, in a study with 193 patients, showed
that smoking status in univariate analysis had a signific-
antimpactalthoughitcouldnotbeconfirmedinmultivari-
ate analysis [19]. Other studies have also been unable
to demonstrate that smoking has an effect on perioper-
ative mortality [4], [22]. Our study could conclude that
smoking has a deteriorating effect on postoperative
morbidity – but not on mortality after pneumonectomy.
Consideringperioperativecomplicationsaswelltheincid-
ence of cardiac arrhythmias (25% versus 7%, p<0.01),
as the rate of bronchopleural fistulas was higher in
smokers than in nonsmokers (9.7% versus 4.6%). We
have not done any protective medication to prevent ar-
rhythmias nor routinely buttressing the bronchial stump.
Orthopaedic surgeons in a randomised study have ob-
served that the healing of wounds and fractures in
smokersafterhipandkneesurgeryisimpaired(deterior-
ation of wound healing in 31% versus 5% for smokers
and nonsmokers respectively, p<0.001) [23]. Healing of
anastomoses in abdominal surgery is also deteriorated
forsmokers[24].Barreraobservedpostoperativepulmon-
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in 23% [25].
The problems in wound healing for smokers could be the
resultofreducedcellularrepairprocessesandadecrease
in tissue oxygenation. Smoking is also a risk factor for
pulmonary infections, probably because of its adverse
effect on respiratory defence processes [26]. Vaporciyan
showed in a retrospective analysis of 257 pneumonec-
tomies that patients who stopped smoking one month
before the operation had significantly less pulmonary
complications (p=0.03) [27].
It can be concluded from our investigation that nicotine
abstinence prior to operation probably reduces mortality
and morbidity after pneumonectomy. However, we did
not find the expected differences between smokers and
nonsmokersconsideringperioperativecomplications.All
methods available for assisting smoking cessation and
nicotine withdrawal (nicotine substitution, psychosocial
therapy) should be employed to stop smoking as early as
possible before lung resection. We have recognised the
importance of this approach and have established a
professional nicotine cessation program to improve the
success rate of surgery for lung cancer. The program
consist a smokers hot line, professional psychological
guided groups and nicotin substitution and medical sup-
port. However, we stop short of postponing patients from
surgery if they are still smokers.
Notes
Acknowledgements
The authors thank Don McClellan for the review of the
manuscript considering English grammar, word choice,
sentence construction and syntax.
Conflicts of interest
None declared.
References
1. WilkinsEWJr,ScannellJG,CraverJG.Fourdecadesofexperience
withresectionsforbronchogeniccarcinomaattheMassachusetts
General Hospital. J Thorac Cardiovasc Surg. 1978;76:364-8.
2. Birim O, Zuydendorp HM, Maat AP, Kappetein AP, Eijkemans MJ,
Bogers AJ. Lung resection for non-small-cell lung cancer in
patients older than 70: mortality, morbidity, and late survival
compared with the general population. Ann Thorac Surg.
2003;76:1796-801. DOI: 10.1016/S0003-4975(03)01064-6
3. Alexiou C, Beggs D, Onyeaka P, Kotidis K, Ghosh S, Beggs L,
Hopkinson DN, Duffy JP, Morgan WE, Rocco G. Pneumonectomy
forstageI(T1N0andT2N0)nonsmallcelllungcancerhaspotent,
adverse impact on survival. Ann Thorac Surg. 2003;76:1023-8.
DOI: 10.1016/S0003-4975(03)00883-X
4. Alexiou C, Beggs D, Rogers ML, Beggs L, Asopa S, Salama FD.
Pneumonectomy for non-small cell lung cancer: predictors of
operative mortality and survival. Eur J Cardiothorac Surg.
2001;20:476-80. DOI: 10.1016/S1010-7940(01)00823-5
5. Brock L. Long survival after operation for cancer of the lung. Br
J Surg. 1975;62:1-5. DOI: 10.1002/bjs.1800620102
6. SwartzDE,LachapelleK,SampalisJ,MulderDS,ChiuRC,Wilson
J. Perioperative mortality after pneumonectomy: analysis of risk
factors and review of the literature. Can J Surg. 1997;40:437-
44.
7. Semik M, Linder A, Horea G, Friedel G, Toomes H. Spezielle
Komplikationen nach organerhaltenden Eingriffen an der Lunge
undderenBehandlung.BronchoplastischeResektionen[Special
complications and feasible therapy after bronchplastic
operations]. Langenbecks Arch Chir. 1993:851-7(Suppl.).
8. Klepetko W, Taghavi S, Pereszlenyi A, Birsan T, Groetzner J,
Kupilik N, Artemiou O, Wolner E. Impact of different coverage
techniques on incidence of postpneumonectomy stump fistula.
EurJCardiothoracSurg.1999;15:758-63.DOI:10.1016/S1010-
7940(99)00089-5
9. Ishida T, Yokoyama H, Kaneko S, Sugio K, Sugimachi K. Long-
term results of operation for non-small cell lung cancer in the
elderly. Ann Thorac Surg. 1990;50:919-22.
10. Patel RL, Townsend ER, Fountain SW. Elective pneumonectomy:
factors associated with morbidity and operative mortality. Ann
Thorac Surg. 1992;54:84-8.
11. al-Kattan K, Sepsas E, Townsend ER, Fountain SW. Factors
affecting long term survival following resection for lung cancer.
Thorax. 1996;51:1266-9.
12. DeslauriersJ,GinsbergRJ,PiantadosiS,FournierB.Prospective
assessmentof30-dayoperativemorbidityforsurgicalresections
in lung cancer. Chest. 1994;106:329S-30S.
13. Stephan F, Boucheseiche S, Hollande J, Flahault A, Cheffi A,
Bazelly B, Bonnet F. Pulmonary complications following lung
resection: a comprehensive analysis of incidence and possible
risk factors. Chest. 2000;118:1263-70. DOI:
10.1378/chest.118.5.1263
14. Friedel G, Graeter T, Haas V, Hammelrath H, Marini A, Stoelben
E, Toomes H. Qualitätssicherung in der Thoraxchirurgie anhand
von Eingriffen beim Bronchialkarzinom [Quality management in
ThoracicSurgeryforthesurgicaltreatmentoflungcancer:results
of a pilot trial]. GMS Thorac Surg Sci. 2004;1:Doc02. Online
available from: http://www.egms.de/en/journals/tss/2004-
1/tss000002.shtml
15. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL,
Batista I, Welch HG, Wennberg DE. Hospital volume and surgical
mortalityintheUnitedStates.NEnglJMed.2002;11;346:1128-
37. DOI: 10.1056/NEJMsa012337
16. Wightman JA. A prospective survey of the incidence of
postoperative pulmonary complications. Br J Surg. 1968;55:85-
91. DOI: 10.1002/bjs.1800550202
17. Fang D, Zhang D, Huang G, Zhang R, Wang L, Zhang D. Results
of surgical resection of patients with primary lung cancer: a
retrospective analysis of 1,905 cases. Ann Thorac Surg.
2001;72:1155-9. DOI: 10.1016/S0003-4975(01)02932-0
18. Cui Y, Zhou D, Peng W, Liu T, Chen H. Determinants of
perioperative morbidity and mortality after pneumonectomy.
Thorac Cardiovasc Surg. 2004;52:45-8. DOI: 10.1055/s-2004-
815801
19. Licker M, Spiliopoulos A, Frey JG, Robert J, Hohn L, de Perrot M,
Tschopp JM. Risk factors for early mortality and major
complications following pneumonectomy for non-small cell
carcinoma of the lung. Chest. 2002;121:1890-7. DOI:
10.1378/chest.121.6.1890
20. Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF,
Deslauriers J, Fry WA, Butz RO, Goldberg M, Waters PF, et al.
Modern thirty-day operative mortality for surgical resections in
lung cancer. J Thorac Cardiovasc Surg. 1983;86:654-8.
5/6 GMS Thoracic Surgical Science 2008, Vol. 5, ISSN 1862-4006
Kirschbaum et al.: Morbidity and mortality after pneumonectomy in smokers ...21. AlgarFJ,AlvarezA,SalvatierraA,BaamondeC,ArandaJL,Lopez-
Pujol FJ. Predicting pulmonary complications after
pneumonectomy for lung cancer. Eur J Cardiothorac Surg.
2003;23:201-8. DOI: 10.1016/S1010-7940(02)00719-4
22. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst
RJ, Weigel TL, Kris MG, Venkatraman ES, Rusch VW. Morbidity
andmortalityafterneoadjuvanttherapyforlungcancer:therisks
of right pneumonectomy. Ann Thorac Surg. 2001;72:1149-54.
DOI: 10.1016/S0003-4975(01)02995-2
23. Lavernia CJ, Sierra RJ, Gomez-Marin O. Smoking and joint
replacement: resource consumption and short-term outcome.
Clin Orthop Relat Res. 1999;367:172-80. DOI:
10.1097/00003086-199910000-00021
24. Kasperk R, Philipps B, Vahrmeyer M, Willis S, Schumpelick V.
Risikofaktoren der Anastomoseninsuffizienz nach sehr tiefer
colorectaler und coloanaler Anastomose [Risk factors for
anastomosisdehiscenceafterverydeepcolorectalandcoloanal
anastomosis]. Chirurg. 2000;71:1365-9. DOI:
10.1007/s001040051227
25. Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS,
WhiteDA.Smokingandtimingofcessation:impactonpulmonary
complications after thoracotomy. Chest. 2005;127:1977-83.
DOI: 10.1378/chest.127.6.1977
26. Murin S, Bilello KS. Respiratory tract infections: another reason
not to smoke. Cleve Clin J Med. 2005;72:916-20.
27. Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR,
Swisher SG, Walsh GL, Nesbitt JC, Putnam JB, Jr. Incidence of
major pulmonary morbidity after pneumonectomy: association
withtimingofsmokingcessation.AnnThoracSurg.2002;73:420-
5; discussion 5-6. DOI: 10.1016/S0003-4975(01)03443-9
Corresponding author:
PD Dr. Godehard Friedel
Klinik Schillerhöhe, Thoraxchirurgie, Solitudestr. 18,
70839, Gerlingen, Deutschland
godehard.friedel@klinik-schillerhoehe.de
Please cite as
Kirschbaum A, Kyriss T, Dippon J, Friedel G. Morbidity and mortality
after pneumonectomy in smokers with NSCLC. GMS Thorac Surg Sci.
2008;5:Doc01.
This article is freely available from
http://www.egms.de/en/journals/tss/2008-5/tss000014.shtml
Published: 2008-08-25
Copyright
©2008 Kirschbaum et al. This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You
are free: to Share — to copy, distribute and transmit the work, provided
the original author and source are credited.
6/6 GMS Thoracic Surgical Science 2008, Vol. 5, ISSN 1862-4006
Kirschbaum et al.: Morbidity and mortality after pneumonectomy in smokers ...